financetom
Business
financetom
/
Business
/
Market Chatter: HSBC Considers Naming Internal Candidates as New CEO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: HSBC Considers Naming Internal Candidates as New CEO
May 15, 2024 7:16 AM

09:48 AM EDT, 05/15/2024 (MT Newswires) -- HSBC Holdings ( HSBC ) is considering naming its new chief executive from a shortlist of internal candidates as it initiates its search for outgoing CEO Noel Quinn's successor, Bloomberg reported Wednesday, citing people familiar with the plan.

Georges Elhedery, the company's chief financial officer, Nuno Matos, the head of wealth and personal banking, are considered the leading candidates to succeed Quinn, the report said.

An external candidate may want to adopt a new strategy, which has prompted the board to be more inclined to support internal talent, the report quoted the sources as saying.

The search for a new CEO is only beginning and the board may still decide to go in another direction, the report said.

HSBC ( HSBC ) did not immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 44.62, Change: -0.10, Percent Change: -0.22

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Astrazeneca Says Interim Data From Breast Cancer Therapy Study Shows Promise
Astrazeneca Says Interim Data From Breast Cancer Therapy Study Shows Promise
Feb 26, 2025
08:59 AM EST, 02/26/2025 (MT Newswires) -- AstraZeneca ( AZN ) said Wednesday that an interim analysis of the phase 3 trial of its experimental therapy, camizestrant, combined with a cyclin-dependent kinase inhibitor showed statistically significant and clinically meaningful improvement in progression-free survival in certain breast cancer patients compared to standard of care. Although key secondary endpoints such as time-to-second...
Kestra Medical Technologies to Launch 10 Million Share IPO, Expected Range at $14 to $16 per Share
Kestra Medical Technologies to Launch 10 Million Share IPO, Expected Range at $14 to $16 per Share
Feb 26, 2025
08:50 AM EST, 02/26/2025 (MT Newswires) -- Kestra Medical Technologies (KMTS) said Wednesday that it is launching an initial public offering of 10 million shares with an expected price range of $14.00 to $16.00 per share. The medical device company said it also offered underwriters a 30-day option to purchase up to 1.5 million additional shares. Kestra said it has...
Federal Realty Investment Trust Buys California Shopping Center for $123.5 Million
Federal Realty Investment Trust Buys California Shopping Center for $123.5 Million
Feb 26, 2025
09:01 AM EST, 02/26/2025 (MT Newswires) -- Federal Realty Investment Trust ( FRT ) said Wednesday it has acquired the Del Monte Shopping Center in Monterey, California, for $123.5 million. The company said it aims to create value at the shopping center through strategic lease-ups, merchandising, and placemaking enhancements. The property, currently 83% leased, serves a trade area of over...
XPEL's Q4 Earnings Fall, Revenue Rises; Q1 Sales Outlook Set
XPEL's Q4 Earnings Fall, Revenue Rises; Q1 Sales Outlook Set
Feb 26, 2025
09:00 AM EST, 02/26/2025 (MT Newswires) -- XPEL ( XPEL ) reported Q4 earnings Wednesday of $0.32 per diluted share, down from $0.43 a year earlier. Two analysts polled by FactSet expected $0.41. Revenue for the quarter ended Dec. 31 was $107.5 million, up from $105.5 million a year earlier. Three analysts polled by FactSet expected $107 million. The company...
Copyright 2023-2026 - www.financetom.com All Rights Reserved